Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Drug-Defying Tuberculosis Reaches Record Levels, Report Says

Feb. 3 (Bloomberg) -- Drug-resistant tuberculosis rose to record levels in 2007-2010, and the highest prevalence was found in parts of eastern Europe and central Asia, a study found.

In Russia’s Murmansk region, the treatment-defying strain of the disease accounted for 29 percent of new and previously treated cases, and in Moldova it was 65 percent, researchers from the World Health Organization wrote in the agency’s Bulletin.

Global trends in multi-drug resistant tuberculosis remain unclear because data are lacking from large countries including India and several African nations, said the researchers, who surveyed 80 countries and eight territories.

To contact the reporter on this story: Simeon Bennett in Geneva at

To contact the editor responsible for this story: Phil Serafino at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.